Febit’s HybSelector, an instrument for high throughput targeted resequencing replaces the Geniom RT Analyzer for high-quality DNA enrichment followed by targeted next-generation sequencing. It combines febit’s expertise in the development and manufacture of technologies for genome exploration with the most advanced high-quality DNA enrichment automation available on the market, according to a company statement.
The economic benefit of HybSelect increases the potential for widespread use of next generation sequencing in clinical studies. Instead of sequencing the complete genomes of only a limited number of patients, HybSelect enables the analysis of specific genes of interest from large patient cohorts for the same price and data management effort. The larger patient pool now provides the statistically relevant data that are necessary for clinical studies.